Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-d-xylulose 5-phosphate reductoisomerase
摘要:
Analogs of the antibiotic fosmidomycin, an inhibitor of the methylerythritol phosphate pathway to isoprenoids, were synthesized and evaluated against the recombinant Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR). Fosfoxacin, the phosphate analog of fosmidomycin, and its acetyl congener were found to be more potent inhibitors of DXR than fosmidomycin. (c) 2005 Elsevier Ltd. All rights reserved.
Collignon, N.; Fabre, G.; Varlet, J. M., Phosphorus and Sulfur and the Related Elements, 1981, vol. 10, p. 81 - 86
作者:Collignon, N.、Fabre, G.、Varlet, J. M.、Savignac, Ph.
DOI:——
日期:——
Modifications around the hydroxamic acid chelating group of fosmidomycin, an inhibitor of the metalloenzyme 1-deoxyxylulose 5-phosphate reductoisomerase (DXR)
Fosmidomycin derivatives in which the hydroxamic acid group has been replaced by several bidentate chelators as potential hydroxamic alternatives were prepared and tested against the DXR from Escherichia coli. These results illustrate the predominant role of the hydroxamate functional group as the most effective metal binding group in DXR inhibitors. (C) 2012 Elsevier Ltd. All rights reserved.
COLLIGNON N.; FABRE G.; VARLET J. M.; SAVIGNAC P., PHOSPH. AND SULFUR, 1981, 10, NO 1, 81-86
作者:COLLIGNON N.、 FABRE G.、 VARLET J. M.、 SAVIGNAC P.
DOI:——
日期:——
Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-d-xylulose 5-phosphate reductoisomerase
作者:Youn-Hi Woo、Roberta P.M. Fernandes、Philip J. Proteau
DOI:10.1016/j.bmc.2005.11.012
日期:2006.4
Analogs of the antibiotic fosmidomycin, an inhibitor of the methylerythritol phosphate pathway to isoprenoids, were synthesized and evaluated against the recombinant Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR). Fosfoxacin, the phosphate analog of fosmidomycin, and its acetyl congener were found to be more potent inhibitors of DXR than fosmidomycin. (c) 2005 Elsevier Ltd. All rights reserved.